Literature DB >> 30790305

Pregnant Women Can Finally Expect Better.

Angela Ballantyne.   

Abstract

A decade of advocacy for the inclusion of pregnant women in the clinical research agenda is starting to pay off. In September, the United States Task Force on Research Specific to Pregnant Women and Lactating Women issued its advice to the secretary of Health and Human Services on addressing gaps in knowledge and research on safe and effective therapies for pregnant women and lactating women. The task force is pushing for major reforms. If its recommendations are taken up, we can anticipate a significant shift in pregnancy research in the United States. This will affect pregnant women, clinicians caring for them, researchers, and institutional review boards.
© 2019 The Hastings Center.

Entities:  

Mesh:

Year:  2019        PMID: 30790305     DOI: 10.1002/hast.971

Source DB:  PubMed          Journal:  Hastings Cent Rep        ISSN: 0093-0334            Impact factor:   2.683


  4 in total

1.  Clinical trials in pregnancy and the "shadows of thalidomide": Revisiting the legacy of Frances Kelsey.

Authors:  Miranda R Waggoner; Anne Drapkin Lyerly
Journal:  Contemp Clin Trials       Date:  2022-05-30       Impact factor: 2.261

Review 2.  Pharmacokinetic studies in pregnancy.

Authors:  Michael J Avram
Journal:  Semin Perinatol       Date:  2020-01-27       Impact factor: 3.300

3.  Exclusion of Pregnant Women from Clinical Trials during the Coronavirus Disease 2019 Pandemic: A Review of International Registries.

Authors:  Devin D Smith; Jessica L Pippen; Adebayo A Adesomo; Kara M Rood; Mark B Landon; Maged M Costantine
Journal:  Am J Perinatol       Date:  2020-05-19       Impact factor: 1.862

4.  Rescuing human fetal tissue research in the United States: A call for additional regulatory reform.

Authors:  Katherine E MacDuffie; Insoo Hyun; Michaela M Krogen; Jennifer C Dempsey; Charles E Murry; Andrew J Copp; Ian A Glass; Dan Doherty
Journal:  Stem Cell Reports       Date:  2021-11-24       Impact factor: 7.765

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.